The Vanguard Group 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

The Vanguard Group 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
11:32 am
Purchase		 2022-12-30 13G Seres Therapeutics, Inc.
MCRB		 The Vanguard Group 6,092,937
4.890%		 1,416,672increase
(+30.29%)		 Filing
2022-02-10
08:37 am
Purchase		 2021-12-31 13G Seres Therapeutics, Inc.
MCRB		 The Vanguard Group 4,676,265
5.090%		 4,676,265increase
(New Position)		 Filing